Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-arm Phase II Randomised Trial of Intermittent Chemotherapy Plus Continuous Cetuximab and of Intermittent Chemotherapy Plus Intermittent Cetuximab in First Line Treatment of Patients With K-ras-normal (Wild-type) Metastatic Colorectal Cancer

NCT00640081 is registered in ClinicalTrials.gov with Cheryl Pugh as lead sponsor.

NCT NCT00640081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-arm Phase II Randomised Trial of Intermittent Chemotherapy Plus Continuous Cetuximab and of Intermittent Chemotherapy Plus Intermittent Cetuximab in First Line Treatment of Patients With K-ras-normal (Wild-type) Metastatic Colorectal Cancer
Lead sponsor
Cheryl Pugh
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
September 30, 2015
Enrollment
169 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer